Impact of Bevacizumab in Ovarian Cancer

April 29, 2015
Robert L. Coleman, MD, FACOG, FACS

Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, discusses a study which examined the impact of bevacizumab in ovarian cancer.